Llywydd, the Member is quite wrong in his description of the position in north Wales. By 8 a.m. yesterday, 31,095 citizens in north Wales had been vaccinated, and that is by some way the highest number of any health board anywhere in Wales. So, far from being held back, actually, the actions of the Betsi Cadwaladr health board are putting them in the lead of vaccination here in Wales. And that is because of the amazing response that we have had from the GP community and the community pharmacy community in north Wales. All 98 primary care practices in Betsi Cadwaladr have indicated that they wish to engage and deliver the AstraZeneca vaccine.

Now, Darren Millar is right that we had hoped to receive 26,000 more doses of the Oxford vaccine than will come our way this week. And that has meant that some plans that were there in north Wales to accelerate still further vaccination have had to be held back. The good news is that the UK Government assure us that we will get that supply next week, in addition to what we were already expecting next week. So that will be a very temporary downturn in the vaccine that we would otherwise expect. 

GPs in their own surgeries are much better equipped to deliver the Oxford vaccine than the Pfizer vaccine, for reasons that many Members will know. The Pfizer vaccine has to be stored in very particular conditions, not simply of temperature but in other conditions as well. It means the Pfizer vaccines are suited for the mass vaccination centres—three of them already in north Wales—and for the hospital-based vaccination centres—three of those in north Wales—and the GP community will focus on the AstraZeneca-Oxford vaccine. The success of that strategy lies behind the very considerable success that we are seeing in north Wales and which I know the Member will want to recognise and to celebrate.